About this data
What it is
Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
Who files it
The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
How current
We collect new notices throughout the day on SEC business days.
Terms
Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
Worth knowing
A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.

All of this comes from public filings.

Form 144 notices per day, last 30 days

0100200300Oct 17 · All notices: 0Oct 17 · Notices that give a 10b5-1 plan: 0Oct 17Oct 18 · All notices: 0Oct 18 · Notices that give a 10b5-1 plan: 0Oct 19 · All notices: 47Oct 19 · Notices that give a 10b5-1 plan: 29Oct 20 · All notices: 52Oct 20 · Notices that give a 10b5-1 plan: 39Oct 21 · All notices: 46Oct 21 · Notices that give a 10b5-1 plan: 26Oct 21Oct 22 · All notices: 49Oct 22 · Notices that give a 10b5-1 plan: 22Oct 23 · All notices: 62Oct 23 · Notices that give a 10b5-1 plan: 23Oct 24 · All notices: 0Oct 24 · Notices that give a 10b5-1 plan: 0Oct 25 · All notices: 0Oct 25 · Notices that give a 10b5-1 plan: 0Oct 25Oct 26 · All notices: 75Oct 26 · Notices that give a 10b5-1 plan: 28Oct 27 · All notices: 71Oct 27 · Notices that give a 10b5-1 plan: 18Oct 28 · All notices: 54Oct 28 · Notices that give a 10b5-1 plan: 17Oct 29 · All notices: 100Oct 29 · Notices that give a 10b5-1 plan: 31Oct 29Oct 30 · All notices: 97Oct 30 · Notices that give a 10b5-1 plan: 35Oct 31 · All notices: 0Oct 31 · Notices that give a 10b5-1 plan: 0Nov 1 · All notices: 0Nov 1 · Notices that give a 10b5-1 plan: 0Nov 2 · All notices: 272Nov 2 · Notices that give a 10b5-1 plan: 133Nov 2Nov 3 · All notices: 142Nov 3 · Notices that give a 10b5-1 plan: 48Nov 4 · All notices: 190Nov 4 · Notices that give a 10b5-1 plan: 77Nov 5 · All notices: 148Nov 5 · Notices that give a 10b5-1 plan: 53Nov 6 · All notices: 127Nov 6 · Notices that give a 10b5-1 plan: 41Nov 6Nov 7 · All notices: 0Nov 7 · Notices that give a 10b5-1 plan: 0Nov 8 · All notices: 0Nov 8 · Notices that give a 10b5-1 plan: 0Nov 9 · All notices: 217Nov 9 · Notices that give a 10b5-1 plan: 75Nov 10 · All notices: 202Nov 10 · Notices that give a 10b5-1 plan: 59Nov 10Nov 11 · All notices: 0Nov 11 · Notices that give a 10b5-1 plan: 0Nov 12 · All notices: 240Nov 12 · Notices that give a 10b5-1 plan: 77Nov 13 · All notices: 127Nov 13 · Notices that give a 10b5-1 plan: 28Nov 14 · All notices: 0Nov 14 · Notices that give a 10b5-1 plan: 0Nov 14Nov 15 · All notices: 0Nov 15 · Notices that give a 10b5-1 plan: 0
0100200300Oct 17 · All notices: 0Oct 17 · Notices that give a 10b5-1 plan: 0Oct 17Oct 18 · All notices: 0Oct 18 · Notices that give a 10b5-1 plan: 0Oct 19 · All notices: 47Oct 19 · Notices that give a 10b5-1 plan: 29Oct 20 · All notices: 52Oct 20 · Notices that give a 10b5-1 plan: 39Oct 21 · All notices: 46Oct 21 · Notices that give a 10b5-1 plan: 26Oct 21Oct 22 · All notices: 49Oct 22 · Notices that give a 10b5-1 plan: 22Oct 23 · All notices: 62Oct 23 · Notices that give a 10b5-1 plan: 23Oct 24 · All notices: 0Oct 24 · Notices that give a 10b5-1 plan: 0Oct 25 · All notices: 0Oct 25 · Notices that give a 10b5-1 plan: 0Oct 25Oct 26 · All notices: 75Oct 26 · Notices that give a 10b5-1 plan: 28Oct 27 · All notices: 71Oct 27 · Notices that give a 10b5-1 plan: 18Oct 28 · All notices: 54Oct 28 · Notices that give a 10b5-1 plan: 17Oct 29 · All notices: 100Oct 29 · Notices that give a 10b5-1 plan: 31Oct 29Oct 30 · All notices: 97Oct 30 · Notices that give a 10b5-1 plan: 35Oct 31 · All notices: 0Oct 31 · Notices that give a 10b5-1 plan: 0Nov 1 · All notices: 0Nov 1 · Notices that give a 10b5-1 plan: 0Nov 2 · All notices: 272Nov 2 · Notices that give a 10b5-1 plan: 133Nov 2Nov 3 · All notices: 142Nov 3 · Notices that give a 10b5-1 plan: 48Nov 4 · All notices: 190Nov 4 · Notices that give a 10b5-1 plan: 77Nov 5 · All notices: 148Nov 5 · Notices that give a 10b5-1 plan: 53Nov 6 · All notices: 127Nov 6 · Notices that give a 10b5-1 plan: 41Nov 6Nov 7 · All notices: 0Nov 7 · Notices that give a 10b5-1 plan: 0Nov 8 · All notices: 0Nov 8 · Notices that give a 10b5-1 plan: 0Nov 9 · All notices: 217Nov 9 · Notices that give a 10b5-1 plan: 75Nov 10 · All notices: 202Nov 10 · Notices that give a 10b5-1 plan: 59Nov 10Nov 11 · All notices: 0Nov 11 · Notices that give a 10b5-1 plan: 0Nov 12 · All notices: 240Nov 12 · Notices that give a 10b5-1 plan: 77Nov 13 · All notices: 127Nov 13 · Notices that give a 10b5-1 plan: 28Nov 14 · All notices: 0Nov 14 · Notices that give a 10b5-1 plan: 0Nov 14Nov 15 · All notices: 0Nov 15 · Notices that give a 10b5-1 plan: 0

All notices Notices that give a 10b5-1 plan

By the day each notice was filed. A notice is a plan to sell, not a sale.

Latest notices of planned insider sales

Reset

Showing: ticker LGND

Latest notices of planned insider sales
FiledInsiderCompanyShares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file.ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for.PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.Expected saleSale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have.Notice
Nov 12, 2026John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
500$162.5K10b5-1Nov 12, 2026—Form 144 ↗
Nov 12, 2026John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
500$158.7K10b5-1Nov 11, 2026—Form 144 ↗
Nov 12, 2026Martine Zimmermann
Director
LGND
Ligand Pharmaceuticals Incorporated
2,000$636.3K—Nov 12, 2026—Form 144 ↗
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
3,000$960.1K—Nov 10, 2026Form 4 ↗
2 days later · 3,000 shares
Form 144 ↗
Nov 4, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
282$90.2K—Nov 4, 2026Form 4 ↗
2 days later · 282 shares
Form 144 ↗
Nov 2, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
700$221.6K—Nov 2, 2026Form 4 ↗
1 day later · 2,111 shares
Form 144 ↗
Oct 30, 2026Jason M Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
1,209$385.2K—Oct 30, 2026Form 4 ↗
4 days later · 2,111 shares
Form 144 ↗
Oct 30, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
202$64.7K—Oct 30, 2026Form 4 ↗
4 days later · 2,111 shares
Form 144 ↗
Sep 10, 2026Martine Zimmermann
Director
LGND
Ligand Pharmaceuticals Incorporated
1,200$342.0K—Sep 10, 2026Form 4 ↗
4 days later · 1,200 shares
Form 144 ↗
Sep 3, 2026Andrew Reardon
Officer
LGND
Ligand Pharmaceuticals Incorporated
15,000$4.3M10b5-1Sep 3, 2026Form 4 ↗
5 days later · 5,000 shares
Form 144 ↗
Aug 12, 2026Octavio Espinoza
Officer
LGND
Ligand Pharmaceuticals Incorporated
31,641$9.1M10b5-1Aug 12, 2026Form 4 ↗
2 days later · 31,641 shares
Form 144 ↗
Aug 12, 2026Jason Haas
Director
LGND
Ligand Pharmaceuticals Incorporated
7,138$2.1M—Aug 12, 2026Form 4 ↗
2 days later · 7,138 shares
Form 144 ↗
Jul 1, 2026Andrew Reardon
Officer
LGND
Ligand Pharmaceuticals Incorporated
10,000$3.2M10b5-1Jul 1, 2026Form 4 ↗
5 days later · 5,000 shares
Form 144 ↗
Jun 16, 2026Stephen L. Sabba
Director
LGND
Ligand Pharmaceuticals Incorporated
2,145$544.8K—Jun 16, 2026Form 4 ↗
2 days later · 2,145 shares
Form 144 ↗
Jun 12, 2026Jason Haas
Director
LGND
Ligand Pharmaceuticals Incorporated
6,461$1.7M—Jun 12, 2026Form 4 ↗
3 days later · 6,461 shares
Form 144 ↗
Jun 11, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
4,500$1.1M—Jun 11, 2026Form 4 ↗
1 day later · 5,000 shares
Form 144 ↗
Jun 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
500$125.0K—Jun 10, 2026Form 4 ↗
2 days later · 5,000 shares
Form 144 ↗
Jun 10, 2026John L Lamattina
Director
LGND
Ligand Pharmaceuticals Incorporated
4,519$1.1M—Jun 10, 2026Form 4 ↗
2 days later · 4,591 shares
Form 144 ↗
Jun 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
5,000$1.2M—Jun 10, 2026Form 4 ↗
2 days later · 5,000 shares
Form 144 ↗
May 13, 2026John Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
1,575$352.0K—May 13, 2026Form 4 ↗
1 day later · 2,034 shares
Form 144 ↗
May 12, 2026John Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
459$102.8K—May 12, 2026Form 4 ↗
2 days later · 2,034 shares
Form 144 ↗
May 1, 2026John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$107.3K10b5-1May 1, 2026Form 4 ↗
13 days later · 2,501 shares
Form 144 ↗
Apr 1, 2026John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$95.0K10b5-1Apr 1, 2026Form 4 ↗
1 day later · 467 shares
Form 144 ↗
Mar 23, 2026Stephen L. Sabba
Director
LGND
Ligand Pharmaceuticals Incorporated
1,000$207.9K—Mar 23, 2026Form 4 ↗
2 days later · 1,000 shares
Form 144 ↗
Mar 11, 2026Octavio Espinoza
Officer
LGND
Ligand Pharmaceuticals Incorporated
3,057$649.0K10b5-1Mar 11, 2026Form 4 ↗
2 days later · 3,057 shares
Form 144 ↗
Mar 6, 2026John L Lamattina
Director
LGND
Ligand Pharmaceuticals Incorporated
2,161$433.8K—Mar 6, 2026Form 4 ↗
25 days later · 2,161 shares
Form 144 ↗
Mar 4, 2026Andrew Reardon
Officer
LGND
Ligand Pharmaceuticals Incorporated
20,000$4.1M10b5-1Mar 4, 2026Form 4 ↗
2 days later · 5,000 shares
Form 144 ↗
Mar 4, 2026Octavio Espinoza
Officer
LGND
Ligand Pharmaceuticals Incorporated
13,423$2.7M10b5-1Mar 4, 2026Form 4 ↗
2 days later · 13,423 shares
Form 144 ↗
Mar 3, 2026Stephen L. Sabba
Director
LGND
Ligand Pharmaceuticals Incorporated
2,034$409.9K—Mar 3, 2026Form 4 ↗
2 days later · 2,034 shares
Form 144 ↗
Feb 2, 2026John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$89.7K10b5-1Feb 2, 2026Form 4 ↗
2 days later · 467 shares
Form 144 ↗
Jan 2, 2026John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$88.1K10b5-1Jan 2, 2026Form 4 ↗
4 days later · 467 shares
Form 144 ↗
Dec 12, 2025Octavio Espinoza
Officer
LGND
Ligand Pharmaceuticals Incorporated
1,804$339.7K—Dec 12, 2025Form 4 ↗
4 days later · 1,804 shares
Form 144 ↗
Dec 1, 2025John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$93.3K10b5-1Dec 1, 2025Form 4 ↗
2 days later · 467 shares
Form 144 ↗
Nov 7, 2025Nancy Gray
Director
LGND
Ligand Pharmaceuticals Incorporated
6,571$1.4M—Nov 7, 2025Form 4 ↗
5 days later · 6,571 shares
Form 144 ↗
Nov 7, 2025John L Lamattina
Director
LGND
Ligand Pharmaceuticals Incorporated
4,179$858.6K—Nov 7, 2025Form 4 ↗
5 days later · 4,179 shares
Form 144 ↗
Nov 3, 2025John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$89.2K10b5-1Nov 3, 2025Form 4 ↗
2 days later · 467 shares
Form 144 ↗
Oct 1, 2025John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$82.5K10b5-1Oct 1, 2025Form 4 ↗
2 days later · 467 shares
Form 144 ↗
Sep 23, 2025Jason M Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
10,000$1.7M—Sep 23, 2025Form 4 ↗
1 day later · 10,000 shares
Form 144 ↗
Sep 17, 2025Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
10,000$1.7M—Sep 17, 2025Form 4 ↗
7 days later · 10,000 shares
Form 144 ↗
Sep 2, 2025John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$75.5K10b5-1Sep 2, 2025Form 4 ↗
2 days later · 467 shares
Form 144 ↗
Aug 1, 2025John W. Kozarich
Director
LGND
Ligand Pharmaceuticals Incorporated
467$61.2K10b5-1Aug 1, 2025Form 4 ↗
4 days later · 467 shares
Form 144 ↗
Jul 10, 2025John W. Kozarich
Officer
LGND
Ligand Pharmaceuticals Incorporated
934$116.8K10b5-1Jul 10, 2025Form 4 ↗
1 day later · 934 shares
Form 144 ↗
Jun 23, 2025Andrew Thomas Reardon
Officer
LGND
Ligand Pharmaceuticals Incorporated
500$57.0K—Jun 23, 2025Form 4 ↗
1 day later · 500 shares
Form 144 ↗
Jun 10, 2025Andrew Thomas Reardon
Officer
LGND
Ligand Pharmaceuticals Incorporated
500$57.3K—Jun 10, 2025Form 4 ↗
2 days later · 500 shares
Form 144 ↗
May 15, 2025Andrew Thomas Reardon
Officer
LGND
Ligand Pharmaceuticals Incorporated
1,000$104.0K—May 15, 2025Form 4 ↗
18 days later · 1,000 shares
Form 144 ↗
Mar 18, 2025Stephen L. Sabba
Director
LGND
Ligand Pharmaceuticals Incorporated
2,406$255.0K—Mar 18, 2025—Form 144 ↗
Mar 4, 2025Espinoza Octavio
Officer
LGND
Ligand Pharmaceuticals Incorporated
5,000$575.1K—Mar 4, 2025Form 4 ↗
2 days later · 5,000 shares
Form 144 ↗
Dec 23, 2024Espinoza Octavio
Officer
LGND
Ligand Pharmaceuticals Incorporated
2,104$244.9K—Dec 23, 2024Form 4 ↗
3 days later · 2,104 shares
Form 144 ↗
Nov 27, 2024John L. Lamattina
Director
LGND
Ligand Pharmaceuticals Incorporated
2,406$286.8K—Nov 26, 2024Form 4 ↗
5 days later · 2,406 shares
Form 144 ↗
Nov 12, 2024Matthew E. Korenberg
Officer
LGND
Ligand Pharmaceuticals Incorporated
32,183$3.9M—Nov 11, 2024—Form 144 ↗

The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:18 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances